← Back to All US Stocks

MRAI Stock Analysis 2026 - Marpai, Inc. AI Rating

MRAI OTC Services-Misc Health & Allied Services, NEC DE CIK: 0001844392
Recently Updated • Analysis: Apr 2, 2026 • SEC Data: 2025-12-31
STRONG SELL
95% Conf
Pending
Analysis scheduled

📊 MRAI Key Takeaways

Revenue: $18.1M
Net Margin: -91.5%
Free Cash Flow: $-7.8M
Current Ratio: 0.40x
Debt/Equity: N/A
EPS: $-0.95
AI Rating: STRONG SELL with 95% confidence

Is MRAI a Good Investment? Thesis Analysis

Claude

Marpai demonstrates severe financial distress with negative stockholders' equity of -$32.6M, indicating the company is technically insolvent. Operating and net margins are deeply negative at -74.9% and -91.5% respectively, while the company is burning cash with -$7.8M in free cash flow, leaving only $133K in cash reserves against $43.5M in liabilities.

Why Buy MRAI? Key Strengths

Claude
  • + Revenue of $18.1M provides a minimal operational base
  • + Net loss improved 25% year-over-year, suggesting loss reduction trend
  • + Flat revenue maintenance indicates some operational stability in core business

MRAI Investment Risks to Consider

Claude
  • ! Negative stockholders' equity of -$32.6M indicates technical insolvency and existential risk
  • ! Critical liquidity crisis with current ratio of 0.40x and only $133K cash against $43.5M liabilities
  • ! Severe operational losses with -$7.5M operating cash burn and -91.5% net margin unsustainable long-term
  • ! Negative ROA of -151.9% and negative interest coverage of -5.0x demonstrate inability to service debt or generate returns
  • ! Long-term debt of $19.4M represents 56% of total liabilities with impaired repayment capacity

Key Metrics to Watch

Claude
  • * Cash position and monthly burn rate to determine runway
  • * Operating cash flow trend toward positive territory
  • * Net margin improvement and path to profitability
  • * Long-term debt refinancing or restructuring developments
  • * Revenue growth acceleration and gross margin expansion

MRAI Financial Metrics

Revenue
$18.1M
Net Income
$-16.6M
EPS (Diluted)
$-0.95
Free Cash Flow
$-7.8M
Total Assets
$10.9M
Cash Position
$133.0K

💡 AI Analyst Insight

The current ratio below 1.0x warrants monitoring of short-term liquidity.

MRAI Profitability Ratios

Gross Margin N/A
Operating Margin -74.9%
Net Margin -91.5%
ROE N/A
ROA -151.9%
FCF Margin -43.2%

MRAI vs Default Sector

How Marpai, Inc. compares to Default sector averages

Net Margin
MRAI -91.5%
vs
Sector Avg 12.0%
MRAI Sector
ROE
MRAI 0.0%
vs
Sector Avg 15.0%
MRAI Sector
Current Ratio
MRAI 0.4x
vs
Sector Avg 1.8x
MRAI Sector
Debt/Equity
MRAI 0.0x
vs
Sector Avg 0.7x
MRAI Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is MRAI Overvalued or Undervalued?

Based on fundamental analysis, Marpai, Inc. has mixed fundamental signals relative to the Default sector in 2026.

Return on Equity
N/A
Sector avg: 15%
Net Profit Margin
-91.5%
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
N/A
Sector avg: 0.7x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

MRAI Balance Sheet & Liquidity

Current Ratio
0.40x
Quick Ratio
0.40x
Debt/Equity
N/A
Debt/Assets
398.6%
Interest Coverage
-5.00x
Long-term Debt
$19.4M

MRAI 5-Year Financial Trend & Growth Analysis

MRAI 5-year financial data: Year 2021: Revenue $14.2M, Net Income -$3.9M, EPS $-1.60. Year 2022: Revenue $24.3M, Net Income -$16.0M, EPS $-1.59. Year 2023: Revenue $37.2M, Net Income -$26.5M, EPS $-5.23.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: Marpai, Inc.'s revenue has grown significantly by 161% over the 5-year period, indicating strong business expansion. The most recent EPS of $-1.92 indicates the company is currently unprofitable.

MRAI Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
-43.2%
Free cash flow / Revenue

MRAI Quarterly Performance

Quarterly financial performance data for Marpai, Inc. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2024 $7.0M -$3.6M $-0.30
Q2 2024 $7.2M -$7.6M $-1.10
Q1 2024 $7.4M -$4.3M $-0.46
Q3 2023 $4.9M -$5.8M $-0.98
Q2 2023 $5.6M -$6.7M $-1.10
Q1 2023 $6.2M -$5.5M $-0.28
Q3 2022 $4.8M -$4.8M $-0.28
Q2 2022 $3.5M -$3.9M $-0.34

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

MRAI Capital Allocation

Operating Cash Flow
-$7.5M
Cash generated from operations
Capital Expenditures
$362.8K
Investment in assets
Dividends
None
No dividend program

MRAI SEC 10-K & 10-Q Filing Analysis

Access official SEC EDGAR filings for Marpai, Inc. (CIK: 0001844392)

📋 Recent SEC Filings

Date Form Document Action
Mar 25, 2026 10-K ea0282918-10k_marpai.htm View →
Mar 11, 2026 8-K ea0280979-8k_marpai.htm View →
Feb 13, 2026 8-K ea0277061-8k_marpai.htm View →
Jan 23, 2026 8-K ea027392101-8k_marpai.htm View →
Dec 23, 2025 8-K ea0270704-8k_marpai.htm View →

Frequently Asked Questions about MRAI

What is the AI rating for MRAI?

Marpai, Inc. (MRAI) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.

What are MRAI's key strengths?

Claude: Revenue of $18.1M provides a minimal operational base. Net loss improved 25% year-over-year, suggesting loss reduction trend.

What are the risks of investing in MRAI?

Claude: Negative stockholders' equity of -$32.6M indicates technical insolvency and existential risk. Critical liquidity crisis with current ratio of 0.40x and only $133K cash against $43.5M liabilities.

What is MRAI's revenue and growth?

Marpai, Inc. reported revenue of $18.1M.

Does MRAI pay dividends?

Marpai, Inc. does not currently pay dividends.

Where can I find MRAI SEC filings?

Official SEC filings for Marpai, Inc. (CIK: 0001844392) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is MRAI's EPS?

Marpai, Inc. has a diluted EPS of $-0.95.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.

Is MRAI a good stock to buy right now?

Based on our AI fundamental analysis in April 2026, Marpai, Inc. has a STRONG SELL rating with 95% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.

Is MRAI stock overvalued or undervalued?

Valuation metrics for MRAI: ROE of N/A (sector avg: 15%), net margin of -91.5% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

Should I buy MRAI stock in 2026?

Our dual AI analysis gives Marpai, Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is MRAI's free cash flow?

Marpai, Inc.'s operating cash flow is $-7.5M, with capital expenditures of $362.8K. FCF margin is -43.2%.

How does MRAI compare to other Default stocks?

Vs Default sector averages: Net margin -91.5% (avg: 12%), ROE N/A (avg: 15%), current ratio 0.40 (avg: 1.8).

Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Apr 2, 2026 | Data as of: 2025-12-31 | Powered by Claude AI